Bradespar SA
F:FXMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bradespar SA
F:FXMA
|
BR |
|
Phunware Inc
NASDAQ:PHUN
|
US |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
|
R
|
Relx PLC
XMUN:RDEB
|
UK |
|
S
|
Sprint Bioscience AB
XMUN:5JA1
|
SE |
|
9
|
908 Devices Inc.
NASDAQ:MASS
|
US |
|
H
|
Hartford Financial Services Group Inc
DUS:HFF
|
US |
Wall St Price Targets
FXMA Price Targets Summary
Bradespar SA
According to Wall Street analysts, the average 1-year price target for FXMA is 3.05 EUR with a low forecast of 2.66 EUR and a high forecast of 3.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FXMA's stock price target?
Price Target
3.05
EUR
According to Wall Street analysts, the average 1-year price target for FXMA is 3.05 EUR with a low forecast of 2.66 EUR and a high forecast of 3.58 EUR.
What is the Revenue forecast for Bradespar SA?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 4 years is 9%.
What is the Operating Income forecast for Bradespar SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for Bradespar SA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 4 years is 8%.
What is the Net Income forecast for Bradespar SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 4 years is 7%.
